Daher Costantine F, Koulajian Khajag B, Haddad Najib, Baroody George M
School of Arts and Sciences, Natural Science Division, Biology Department, Lebanese American University, Byblos, Lebanon.
J Toxicol Environ Health A. 2006 Sep;69(17):1587-601. doi: 10.1080/15287390500468688.
Hydroxycut, an herbal supplement not currently defined as a drug, is frequently sold over the counter to increase exercise performance, build muscles, and burn fat. The effects of 8 wk of hydroxycut-induced changes on blood lipid profile in rats fed with either regular or high-fat diet were evaluated. Regardless of fat content in the diet, the doses of hydroxycut used significantly decreased fasting serum concentrations of cholesterol, triacylglycerol (TAG), low-density lipoprotein (LDL) cholesterol, total apolipoprotein B (apo B), and LDL/high-density lipoprotein (HDL) cholesterol ratio. A significant increase in serum blood glucose level was observed with hydroxycut intake in the presence of a high-fat diet. No hydroxycut-related changes in serum activities of serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate dehydrogenase (SGPT), lactate dehydrogenase (LDH), and creatinine phosphokinase (CPK) enzymes were noted, indicating no liver damage occurred. A decrease in liver fat content was observed with hydroxycut intake. The drug did not affect the number and composition of secreted very-low-density lipoprotein (VLDL) particles except for a decrease in VLDL TAG when the fat content in the diet was high. Hydroxycut reduced significantly LDL apo B and LDL TAG and cholesterol concentrations. Hydroxycut increased TAG and cholesterol excretion in feces. A single intragastric food load containing hydroxycut reduced significantly postprandial plasma TAG concentration in a dose-dependent manner. In conclusion, hydroxycut intake in recommended doses exerts a beneficial impact on atherosclerosis, an effect attributed to improved clearance and metabolism of lipoprotein particles, and to a lesser extent to an increased excretion of TAG and cholesterol in the feces. More studies are needed to ensure the safety of long-term use of hydroxycut.
Hydroxycut是一种目前未被定义为药物的草本补充剂,常作为非处方药出售,用于提高运动表现、增强肌肉和燃烧脂肪。本研究评估了连续8周服用Hydroxycut对喂食常规饮食或高脂饮食大鼠血脂谱的影响。无论饮食中的脂肪含量如何,所使用的Hydroxycut剂量均显著降低了空腹血清中胆固醇、三酰甘油(TAG)、低密度脂蛋白(LDL)胆固醇、总载脂蛋白B(apo B)以及LDL/高密度脂蛋白(HDL)胆固醇比值的浓度。在高脂饮食情况下,摄入Hydroxycut会导致血清血糖水平显著升高。未观察到与Hydroxycut相关的血清谷氨酸草酰乙酸转氨酶(SGOT)、血清谷氨酸丙酮酸脱氢酶(SGPT)、乳酸脱氢酶(LDH)和肌酸磷酸激酶(CPK)酶活性的变化,表明未发生肝损伤。摄入Hydroxycut后,肝脏脂肪含量有所降低。当饮食中的脂肪含量较高时,该药物除了使极低密度脂蛋白(VLDL)TAG含量降低外,对分泌的VLDL颗粒数量和组成没有影响。Hydroxycut显著降低了LDL apo B以及LDL TAG和胆固醇的浓度。Hydroxycut增加了粪便中TAG和胆固醇的排泄。单次胃内给予含Hydroxycut的食物负荷可显著降低餐后血浆TAG浓度,且呈剂量依赖性。总之,按推荐剂量摄入Hydroxycut对动脉粥样硬化具有有益影响,这一作用归因于脂蛋白颗粒清除和代谢的改善,以及粪便中TAG和胆固醇排泄的少量增加。需要更多研究来确保长期使用Hydroxycut的安全性。